T1	Participants 1528 1648	CONCLUSIONS The results revealed that the efficacy and side effects of mitoxantrone were similar to those of doxorubicin
T2	Participants 816 865	RESULTS The median follow-up period was 36 months
T3	Participants 355 441	METHODS Sixty-three patients were randomized into mitoxantrone and doxorubicin groups.
T4	Participants 0 132	A randomized trial comparing intravesical instillations of mitoxantrone and doxorubicin in patients with superficial bladder cancer.
